p27<sup>kip1</sup>: a target for tumor therapies?
<p>Abstract</p> <p>The cyclin kinase inhibitor p27<sup>kip1 </sup>acts as a potent tumor supressor protein in a variety of human cancers. Its expression levels correlate closely with the overall prognosis of the affected patient and often predict the outcome to differen...
Main Authors: | Kossatz Uta, Zender Steffen, Nickeleit Irina, Malek Nisar P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-05-01
|
Series: | Cell Division |
Online Access: | http://www.celldiv.com/content/2/1/13 |
Similar Items
-
Regulation of p27<sup>Kip1</sup> and p57<sup>Kip2</sup> Functions by Natural Polyphenols
by: Gian Luigi Russo, et al.
Published: (2020-09-01) -
Immunohistochemical Expression of p27<sup>Kip1</sup>, p57<sup>Kip2</sup>, Cyclin D1, Nestin, and Ki-67 in Ependymoma
by: Shahad Iqneibi, et al.
Published: (2022-02-01) -
The AMPK/p27<sup>Kip1</sup> Pathway as a Novel Target to Promote Autophagy and Resilience in Aged Cells
by: Lauren K. McKay, et al.
Published: (2021-06-01) -
The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27<sup>KIP1</sup>
by: Glòria García-Galindo, et al.
Published: (2021-03-01) -
p27<sup>Kip1</sup> and Tumors: Characterization of <i>CDKN1B</i> Variants Identified in MEN4 and Breast Cancer
by: Debora Bencivenga, et al.
Published: (2025-01-01)